Gastroenterology
Conference Coverage
Eccentric exercise tamed elevated liver enzymes
Major finding: An exercise regimen of regular downhill walking for 8 weeks lowered serum alanine aminotransferase levels in overweight and obese...
News
Posaconazole disappoints against chronic Chagas’ disease
Major finding: The primary end point of the study, consistently negative results on serial T.
News
Undiagnosed joint hypermobility syndrome prevalent in GI clinics
Major finding: Joint hypermobility syndrome is significantly associated with gastrointestinal symptoms such as abdominal pain, bloating, and...
News
UPDATED: FDA-released safety data on dabigatran vs. warfarin reassuring
Major finding: The risks of ischemic stroke, intracranial hemorrhage, and death associated with dabigatran treatment were lower than with warfarin...
Conference Coverage
PEARL-II: Oral ‘3D’ regimen effective in hepatitis C with prior treatment failure
Major finding: Noncirrhotic patients with hepatitis C genotype 1b disease who had failed previous pegylated interferon–based therapy had a 100%...
Conference Coverage
Oral PPI therapy gets nod following bleeding ulcer repair
Major finding: Oral proton pump inhibitor therapy can safely and effectively replace the guideline-recommended standard regimen consisting of a...
Conference Coverage
Think ‘celiac disease’ in patients requiring high-dose levothyroxine
Major finding: Five percent of hypothyroid patients who needed 125 mcg or more of levothyroxine daily in order to remain euthyroid proved to have...
Conference Coverage
Polyp, adenoma detection rises with Endocuff device
Major finding: The polyp detection rate was 56% for Endocuff-assisted colonoscopy and 42% for standard colonoscopy (P = .001).Data source: A...
News
Amyloid deposition may be aggravated in small-vessel disease
Key clinical point: The pathways of small-vessel disease and Alzheimer’s pathology might be interconnected.Major finding: Both microbleeds and...
Conference Coverage
Eluxadoline scores in phase III for irritable bowel syndrome
Major finding: Thirty-one percent of patients with diarrhea-predominant irritable bowel syndrome on 100 mg b.i.d.
Conference Coverage
Larazotide eased symptoms in phase II celiac trial
Major finding: Patients with symptomatic celiac disease despite being on a gluten-free diet showed a 26% greater reduction in a composite symptom...